The growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, has updated on recent contract wins. The announcement demonstrates that not only can Venn win significant business from Biotechnology clients who may prefer to work with smaller less rigid CROs, but also that the Company can win framework agreements with major Pharmaceutical clients, providing another found
03 Aug 2016
Punching hard
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Punching hard
hVIVO plc (HVO:LON) | 28.2 0.2 2.7% | Mkt Cap: 192.2m
- Published:
03 Aug 2016 -
Author:
Derren Nathan -
Pages:
6
The growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, has updated on recent contract wins. The announcement demonstrates that not only can Venn win significant business from Biotechnology clients who may prefer to work with smaller less rigid CROs, but also that the Company can win framework agreements with major Pharmaceutical clients, providing another found